Global Injectable Drug Delivery Devices Market Growth, Trends and Forecasts (2017 - 2022)

The global drug delivery devices market is currently estimated to be valued at USD 215 billion for the year 2014 and is expected to grow at a CAGR of approximately 9.3% CAGR from 2014 to 2021. Currently, North America dominates the global market owing to the fact that there is greater awareness and per capita incomes. The Asia-Pacific region is expected to show good growth in the future primarily due to the increased awareness among the population. The major trend driving the drug delivery devices market is the major need for controlled release of drugs.

This escalation is developing the need to analyze, review and forecast the growth of the drug delivery devices market. Owing to the rapid evolution in the use of injectable drug delivery technology, medical device companies that are able to launch new innovative equipment will be awarded huge benefits.

Global Injectable Drug Delivery Market- Market Dynamics

The report details several driving and restraining factors for the global injectable drug delivery market. Some of them are listed below.


Increased prevalence of chronic diseases

Technological advances

Increase in individual therapy

Increased understanding about drug metabolism among the population

Need for controlled drug release


Fear of injuries and infections during use

High cost of development

Strict regulatory framework

The global drug delivery devices market is segmented on the basis of mode of delivery -Nasal (Nasal Drops, Nasal Sprays, Nasal Inhalers, and Others), Oral (Dissolution controlled systems, Diffusion-controlled systems, Osmotic pressure controlled systems, pH - independent formulations, Ion -exchange resin drug complexes, Slow dissolving salts & complexes, and Hydrodynamic pressure controlled system), Ocular (Eye Drops, Ointments & Gels, and Others), Implantable (Drug Eluting Stents, Contraceptives, Brachytherapy Seeds, and Intravitreal Implants), Injectable (Conventional Drug Delivery, and Self-Injected Drug Delivery), Transdermal, Topical, Pulmonary and Rectal) and on the basis of region (North America, Europe, Asia-Pacific & Rest of the World).

Some of the key players in the market are:

Alkermes Inc.

Bend Research

BIND Biosciences, Inc.


Genentech Inc.

MicroCHIPS, Inc.

Pearl Therapeutics Inc.

Polymer Factory

Presage Bioscience

QLT Inc.

UCB Group

What the Report Offers

Market definition for the drug delivery device market along with identification of key drivers and restraints for the market.

Market analysis for the drug delivery device market in the healthcare industry, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the drug delivery device market in the healthcare industry on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.


1.1 Report Description

1.2 Research Methodology

1.3 Stakeholders


2.1Key Findings

2.2Market Overview


3.1 Market Definition

3.1.1 Introduction

3.1.2 Modes of Injectable Drug Delivery systems

3.2 Market Drivers

3.2.1 Increasing prevalence of Chronic Diseases

3.2.2 Increased Demand

3.2.3 Technological Advances

3.3 Market Limitations

3.3.1 Injuries and Infections

3.3.2 Recent Advancements

3.3.3 Regulatory Framework

3.4 Market Challenges

3.4.1 Sustainability

3.5 Market Opportunities

3.5.1 Emerging Countries

4. Global Injectable Drug Delivery Technology Market by TYPES

4.1 Introduction

4.2 Conventional Drug Delivery Devices

4.2.1 Injectable Solutions

4.2.2 Solutions

4.2.3 Suspensions

4.2.4 Emulsions

4.3 Novel Drug Delivery Devices

4.3.1 Liposomes

4.3.2 Niosomes

4.3.3 Nanosuspensions

4.3.4 Nanoemulsions/Microemulsion

4.3.5 Solid-Lipid Nanoparticles

4.3.6 Microparticles

4.3.7 Microspheres

4.3.8 Released Erythrocytes


5.1 North America

5.1.1 US

5.1.2 Canada

5.2 Europe

5.2.1 UK

5.2.2 Germany

5.2.3 France

5.3 APAC

5.3.1 India

5.3.2 China

5.3.3 South Korea

5.3.4 Japan

5.4 Rest of the World

5.4.1 Brazil

5.4.2 Middle East

5.4.3 Australia

6. Competitive Landscape

6.1 Introduction

6.2 Mergers & Acquisitions

6.3 Expansions

6.4 New Product Launch

6.5 Collaborations

7. Top Company Profiles

7.1 Alkermes Inc.

7.2 Genentech Inc.

7.3 Bend Research

7.4 QLT Inc.

7.5 Endocyte

7.6 BIND Biosciences, Inc.

7.7 UCB Group (UCB)

7.8 Presage Bioscience

7.9 Polymer Factory

7.10 MicroCHIPS, Inc.

7.11 Pearl Therapeutics Inc.

7.12 Piedmont Pharmaceuticals

7.13 Zogenix, Inc.

7.14 Liquidia Technologies

7.15 Impax Laboratories Inc.

7.16Boehringer Ingelheim

7.17 Crossject Medical Technology

7.18 Apogee Technology

7.19 Pulmatrix

7.20 Medicago

8. Appendix

Content are not available

Choose License Type